CSPC Pharmaceutical Group Ltd
01093: XHKG (HKG)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
HKD 3.80 | Wvxngsl | Qvbmlyl |
CSPC’s Second Quarter In Line; FVE Unchanged at HKD 11.10, Shares Fairly Valued
Narrow-moat CSPC’s second-quarter earnings were in line with our expectations. We maintain our fair value estimate of HKD 11.10 per share. Although the market price is a 12% discount to our fair value, we view this as within the range of fair value given the very high uncertainty rating.